Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Bristol-Myers Squibb (HIV R&D assets)

Bristol-Myers Squibb (HIV R&D assets)
M&A STATUS
Asset Purch. LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Development of HIV medicines. The unit engages in the research and development of HIV medicines and performing pre-clinical trials and set discovery phases.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Acquirer
Primary Office
  • 345 Park Avenue
  • New York, NY 10154
  • United States

Bristol-Myers Squibb (HIV R&D assets) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Bristol-Myers Squibb (HIV R&D assets)‘s full profile, request access.

Request full access to PitchBook

Bristol-Myers Squibb (HIV R&D assets) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Bristol-Myers Squibb (HIV R&D assets)‘s full profile, request access.

Request full access to PitchBook